Latest filing published 06 Jul 2026 for ImmunityBio, Inc., €92k.
Filing timeline
BuySaleInsider track record
Christobel Selecky: trading record in brief
All filings by Christobel Selecky on record concern ImmunityBio, Inc., in the capacity of senior executive. The record holds 5 filings, for trades running from 16 January 2026 to 1 July 2026.
Sales make up the whole of the open-market record (1 sale, €1.3M). Other entries cover 4 option exercises.
Most recently, on 6 July 2026, the filings show an option exercise worth €92k in ImmunityBio, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christobel Selecky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,064 shares@ US$2.980.0011% mcap4.9% of flowCommon StockSEC:0001849739-26-000014:0
- 124,414 shares@ US$2.990.0041% mcap17.4% of flowCommon StockSEC:0001849739-26-000014:1
- 159,478 shares@ US$9.02360.016% mcap67.5% of flowCommon StockSEC:0001849739-26-000014:2
- 25,000 shares@ US$2.980.0008% mcap3.4% of flowCommon StockSEC:0001849739-26-000004:0
- 50,000 shares@ US$2.980.0015% mcap6.8% of flowCommon StockSEC:0001849739-26-000002:0
5 of 5 declarations
